Neoadjuvant chemotherapy with gemcitabine and S-1 for resectable and borderline pancreatic ductal adenocarcinoma: A prospective, multi-institutional, phase II trial

被引：2
|
作者：
Mizuma, Masamichi
Motoi, Fuyuhiko
Ishida, Kazuyuki
Fujishima, Fumiyoshi
Ottomo, Shigeru
Oikawa, Masaya
Okada, Takaho
Shimamura, Hiromune
Takemura, Shinichi
Ono, Fuminori
Akada, Masanori
Nakagawa, Kei
Katayose, Yu
Egawa, Shinichi
Unno, Michiaki
机构：
[1] Tohoku Univ, Grad Sch Med, Dept Surg, Sendai, Miyagi 980, Japan
[2] Iwate Med Univ, Dept Mol Diagnosit Pathol, Morioka, Iwate 020, Japan
[3] Tohoku Univ, Grad Sch Med, Dept Pathol, Sendai, Miyagi 980, Japan
[4] Sendai Open Hosp, Sendai, Miyagi, Japan
[5] Sendai Med Ctr, Sendai, Miyagi, Japan
[6] Shirakawa Kousei Hosp, Shirakawa, Japan
[7] Senboku Kumiai Gen Hosp, Dept Surg, Daisen, Japan
[8] South Miyagi Med Ctr, Dept Surg, Ogawara, Japan
[9] Tohoku Univ, Grad Sch Med, Div Integrated Surg & Oncol, Sendai, Miyagi 980, Japan
[10] Tohoku Univ, Int Res Inst Disaster Sci, Sendai, Miyagi 980, Japan
[11] Tohoku Univ, Sch Med, Sendai, Miyagi 980, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 03期
关键词：
D O I：
10.1200/jco.2014.32.3_suppl.283
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
283
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Neoadjuvant Chemotherapy with Gemcitabine and S-1 for Resectable and Borderline Pancreatic Ductal Adenocarcinoma: Results from a Prospective Multi-institutional Phase 2 Trial
    Fuyuhiko Motoi
    Kazuyuki Ishida
    Fumiyoshi Fujishima
    Shigeru Ottomo
    Masaya Oikawa
    Takaho Okada
    Hiromune Shimamura
    Shinichi Takemura
    Fuminori Ono
    Masanori Akada
    Kei Nakagawa
    Yu Katayose
    Shinichi Egawa
    Michiaki Unno
    Annals of Surgical Oncology, 2013, 20 : 3794 - 3801
  • [2] Neoadjuvant Chemotherapy with Gemcitabine and S-1 for Resectable and Borderline Pancreatic Ductal Adenocarcinoma: Results from a Prospective Multi-institutional Phase 2 Trial
    Motoi, Fuyuhiko
    Ishida, Kazuyuki
    Fujishima, Fumiyoshi
    Ottomo, Shigeru
    Oikawa, Masaya
    Okada, Takaho
    Shimamura, Hiromune
    Takemura, Shinichi
    Ono, Fuminori
    Akada, Masanori
    Nakagawa, Kei
    Katayose, Yu
    Egawa, Shinichi
    Unno, Michiaki
    ANNALS OF SURGICAL ONCOLOGY, 2013, 20 (12) : 3794 - 3801
  • [3] A Prospective Phase II Trial of Neoadjuvant S-1 with Concurrent Hypofractionated Radiotherapy in Patients with Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma
    Keiichi Okano
    Hironobu Suto
    Minoru Oshima
    Eri Maeda
    Naoki Yamamoto
    Keitaro Kakinoki
    Hideki Kamada
    Tsutomu Masaki
    Shigeo Takahashi
    Toru Shibata
    Yasuyuki Suzuki
    Annals of Surgical Oncology, 2017, 24 : 2777 - 2784
  • [4] A Prospective Phase II Trial of Neoadjuvant S-1 with Concurrent Hypofractionated Radiotherapy in Patients with Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma
    Okano, Keiichi
    Suto, Hironobu
    Oshima, Minoru
    Maeda, Eri
    Yamamoto, Naoki
    Kakinoki, Keitaro
    Kamada, Hideki
    Masaki, Tsutomu
    Takahashi, Shigeo
    Shibata, Toru
    Suzuki, Yasuyuki
    ANNALS OF SURGICAL ONCOLOGY, 2017, 24 (09) : 2777 - 2784
  • [5] Benefits of neoadjuvant chemotherapy with gemcitabine plus S-1 for resectable pancreatic ductal adenocarcinoma
    Hirashita, Teijiro
    Tada, Kazuhiro
    Nagasawa, Yuiko
    Orimoto, Hiroki
    Kawamura, Masahiro
    Fujinaga, Atsuro
    Takayama, Hiroomi
    Kawano, Yoko
    Masuda, Takashi
    Endo, Yuichi
    Inomata, Masafumi
    MOLECULAR AND CLINICAL ONCOLOGY, 2025, 22 (02)
  • [6] Clinical Significance of Neoadjuvant Chemotherapy With Gemcitabine Plus S-1 for Resectable Pancreatic Ductal Adenocarcinoma
    Suzuki, Takashi
    Mori, Shozo
    Shimizu, Takayuki
    Tago, Kazuma
    Harada, Nobuhiro
    Park, Kyung-Hwa
    Sakuraoka, Yuhki
    Shiraki, Takayuki
    Iso, Yukihiro
    Aoki, Taku
    Kubota, Keiichi
    IN VIVO, 2019, 33 (06): : 2027 - 2035
  • [7] Prospective phase II trial of Neoadjuvant chemotherapy with gemcitabine and cisplatin for resectable adenocarcinoma of the pancreatic head
    Heinrich, Stefan
    Pestalozzi, Bernhard C.
    Schaefer, Markus
    Weber, Achim
    Bauerfeind, Peter
    Knuth, Alexander
    Clavien, Pierre-Alain
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15) : 2526 - 2531
  • [8] A case of necrotic enteritis during neoadjuvant chemotherapy with gemcitabine and S-1 for resectable pancreatic ductal adenocarcinoma
    Takaaki Furukawa
    Takashi Sasaki
    Yoshihiro Ono
    Fumihiro Kawano
    Manabu Takamatsu
    Chinatsu Mori
    Takafumi Mie
    Yuto Yamada
    Takeshi Okamoto
    Tsuyoshi Takeda
    Akiyoshi Kasuga
    Masato Matsuyama
    Masato Ozaka
    Yu Takahashi
    Naoki Sasahira
    Clinical Journal of Gastroenterology, 2021, 14 : 1571 - 1577
  • [9] A case of necrotic enteritis during neoadjuvant chemotherapy with gemcitabine and S-1 for resectable pancreatic ductal adenocarcinoma
    Furukawa, Takaaki
    Sasaki, Takashi
    Ono, Yoshihiro
    Kawano, Fumihiro
    Takamatsu, Manabu
    Mori, Chinatsu
    Mie, Takafumi
    Yamada, Yuto
    Okamoto, Takeshi
    Takeda, Tsuyoshi
    Kasuga, Akiyoshi
    Matsuyama, Masato
    Ozaka, Masato
    Takahashi, Yu
    Sasahira, Naoki
    CLINICAL JOURNAL OF GASTROENTEROLOGY, 2021, 14 (05) : 1571 - 1577
  • [10] Efficacy of Neoadjuvant Chemotherapy Using Gemcitabine and S-1 for Resectable and Borderline Resectable Pancreatic Cancer
    Aoki, T.
    Mori, S.
    Sakuraoka, Y.
    Suzuki, T.
    Nishi, Y.
    Arakawa, T.
    Shimizu, T.
    Tago, K.
    Park, K. H.
    Harada, N.
    Shiraki, T.
    Iso, Y.
    Kubota, K.
    PANCREAS, 2019, 48 (10) : 1404 - 1404
12345